Product News and Recalls

Topamax Lawsuit Results in $4 Million Verdict

A $4 million verdict has been reached in a Topamax lawsuit against Johnson & Johnson’s Pharmaceutical unit Janssen.

On October 30 , 2013, a Philadelphia jury sided with the woman who took Topamax for six months during her pregnancy and gave birth to a boy with cleft lip. The suit alleged Janssen’s flawed drug Topamax was the cause of a severe birth defect in a baby boy. Four surgeries were needed to correct the extensive injury.

The Plaintiff’s attorney stated that “This was our first case to go to trial and there are many more behind it. This will expose the company to many more lawsuits.” According to The Star Ledger, this case is the first of 134 cases pending in state court in Philadelphia over Topamax, but hundreds of Topomax lawsuits have been filed across the United States, claiming that Topamax caused cleft lip, cleft palate, or other birth defects.

Topamax is an anti-seizure drug manufactured by Johnson & Johnson.  Approved by the FDA in 1996,  it was also prescribed to treat migraines and bi-polar disorder.

You should consult with a medical professional before altering your medical care. If you or a loved one used Topamax during pregnancy and gave birth to a child with cleft lip, cleft palate or other birth defects, contact Lopez McHugh, LLP for a free Topamax lawsuit consultation.